Literature DB >> 22260708

Histone H4 histidine phosphorylation: kinases, phosphatases, liver regeneration and cancer.

Paul G Besant1, Paul V Attwood.   

Abstract

Phosphorylation of histone H4 on one or both of its two histidine residues has been known to occur in liver cells for nearly 40 years and has been associated with proliferation of hepatocytes during regeneration of the liver following mechanical damage. More recently, large increases in histone H4 histidine kinase activity have been found to occur associated with proliferation and differentiation of liver progenitor cells following chemical damage that prevents hepatocyte proliferation. In addition, it has been shown this histone H4 histidine kinase activity is elevated nearly 100-fold in human foetal liver and several hundredfold in hepatocellular carcinoma tissue compared with normal adult liver. In the present paper, we review what is currently known about histone H4 histidine phosphorylation, the kinase(s) responsible and the phosphatases capable of catalysing its dephosphorylation, and briefly summarize the techniques used to detect and measure the histidine phosphorylation of histone H4 and the corresponding kinase activity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22260708     DOI: 10.1042/BST20110605

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  15 in total

Review 1.  Histones: at the crossroads of peptide and protein chemistry.

Authors:  Manuel M Müller; Tom W Muir
Journal:  Chem Rev       Date:  2014-10-20       Impact factor: 60.622

Review 2.  Quantitative proteomic analysis of histone modifications.

Authors:  He Huang; Shu Lin; Benjamin A Garcia; Yingming Zhao
Journal:  Chem Rev       Date:  2015-02-17       Impact factor: 60.622

3.  Monoclonal 1- and 3-Phosphohistidine Antibodies: New Tools to Study Histidine Phosphorylation.

Authors:  Stephen Rush Fuhs; Jill Meisenhelder; Aaron Aslanian; Li Ma; Anna Zagorska; Magda Stankova; Alan Binnie; Fahad Al-Obeidi; Jacques Mauger; Greg Lemke; John R Yates; Tony Hunter
Journal:  Cell       Date:  2015-07-02       Impact factor: 41.582

Review 4.  The Mechanism and Function of Epigenetics in Uterine Leiomyoma Development.

Authors:  Qiwei Yang; Aymara Mas; Michael P Diamond; Ayman Al-Hendy
Journal:  Reprod Sci       Date:  2015-04-28       Impact factor: 3.060

Review 5.  pHisphorylation: the emergence of histidine phosphorylation as a reversible regulatory modification.

Authors:  Stephen Rush Fuhs; Tony Hunter
Journal:  Curr Opin Cell Biol       Date:  2017-01-25       Impact factor: 8.382

Review 6.  Epigenetic regulation of persistent pain.

Authors:  Guang Bai; Ke Ren; Ronald Dubner
Journal:  Transl Res       Date:  2014-05-29       Impact factor: 7.012

7.  Histone Tail Sequences Balance Their Role in Genetic Regulation and the Need To Protect DNA against Destruction in Nucleosome Core Particles Containing Abasic Sites.

Authors:  Kun Yang; Marc M Greenberg
Journal:  Chembiochem       Date:  2018-11-15       Impact factor: 3.164

8.  Glucose Drives Growth Factor-Independent Esophageal Cancer Proliferation via Phosphohistidine-Focal Adhesion Kinase Signaling.

Authors:  Jianliang Zhang; Irwin H Gelman; Eriko Katsuta; Yuanzi Liang; Xue Wang; Jun Li; Jun Qu; Li Yan; Kazuaki Takabe; Steven N Hochwald
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2019-03-02

9.  Strong anion exchange-mediated phosphoproteomics reveals extensive human non-canonical phosphorylation.

Authors:  Gemma Hardman; Simon Perkins; Philip J Brownridge; Christopher J Clarke; Dominic P Byrne; Amy E Campbell; Anton Kalyuzhnyy; Ashleigh Myall; Patrick A Eyers; Andrew R Jones; Claire E Eyers
Journal:  EMBO J       Date:  2019-08-21       Impact factor: 11.598

10.  Determining novel candidate anti-hepatocellular carcinoma drugs using interaction networks and molecular docking between drug targets and natural compounds of SiNiSan.

Authors:  Qin Zhang; Zhangying Feng; Mengxi Gao; Liru Guo
Journal:  PeerJ       Date:  2021-02-16       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.